It has been shown that miR-29a acts as an inhibiting regulator of TCL1A in CLL [88], and as miR-29 has a reduction in expression, TCL1A demonstrated the corresponding increase in expression in those cases. This evidence concerns the gene TCL1A and B-cell chronic lymphocytic leukemia.